Currently, Twist Bioscience Corp’s (TWST) stock is trading at $27.88, marking a fall of -0.26% from last night’s close. At this price, the stock is -49.62% below its 52-week high of $55.33 and 15.82% above its 52-week low of $24.07.
As well, it is important to consider TWST stock ratios such as price-to-sales, which is currently 4.65.TWST’s price to book ratio for the most recent quarter was 3.51, resulting in an 6.71 price to cash per share for the period.
How does Twist Bioscience Corp (TWST) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Twist Bioscience Corp (TWST): Earnings History
If we examine Twist Bioscience Corp’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.47, slashing the consensus of -$0.57. In other words, it beat the consensus by $0.1, resulting in a 18.11% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.47 in contrast with the Outlook of -$0.57. That was a difference of $0.1 and a surprise of 18.11%.
Twist Bioscience Corp (NASDAQ: TWST) Ownership Details
I will give a breakdown of the key shareholders in Twist Bioscience Corp (TWST). Recent figures show that the company’s insiders hold 1.86% of shares. A total of 359 institutional investors hold shares in the company, making 115.92% of its stock and 118.12% of its float.
Jul 31, 2025, it was reported that the Company’s largest institutional holder is ARK ETF Trust-ARK Innovation ETF holding total of 4.08 shares that make 6.76% of the company’s total number of shares and are currently priced at 114.94 million.
The securities firm ARK ETF Trust-ARK Genomic Revolution ETF holds 2.1 shares of TWST, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 3.49%, and the holding percentage of shares is valued at 59.25 million.
